Home About Us Contact Us

 

Table of Content - Volume 13 Issue 1 - Janauary 2020


 

Profile of snake bite patients and their outcome: Our experience at a tertiary care hospital in Vadodara

 

Meenakshi Shah1, Archana Asher2*, Kedar Mehta3

 

{1 Associate Professor, Department of Medicine} {3Assistant Professor, Department of Community Medicine} GMERS Medical College and General Hospital, Gotri – Vadodara, Gujarat, INDIA.

2Assistant Professor, Department of Medicine, GMERS Medical College and Hospital, Vadnagar, Gujarat, INDIA.

Email: archanaasher258@yahoo.co.in

 

Abstract              Background: Snake bite is a common medical emergency in a tropical country like India where a majority of people depend on agriculture for their livelihood. Objective - To study the profile and outcome of snake bite patients. Material and Methods: This was a retrospective study carried out in GMERS Medical College and General Hospital, Gotri-Vadodara from 1st January 2017 to 31st December 2018. Records of 114 snake bite patients were studied, data was collected and statistically analysed. Observation: 114 patients were admitted with snake bite. 28.1% patients belonged to age group of 31 – 40 years. A majority of patients were males (52.6%), married (82.5%), and from rural areas (81.6%). 39.5 % patients were farmers. More incidents occurred in July-September (64.9%), during day time (56.1%). outdoors (57 %) and were unprovoked (99.1%). 85 % patients came directly to our hospital. 52.6% patients were bitten over lower limbs. Most common presenting features were local pain (78.9%), fang marks (76.3%), local swelling (74.6%), and respiratory paralysis (14.9%). Neurotoxicity was present in 14.9% patients. Conclusion: Need for mechanical ventilation, inotropic support, total leucocyte count on presentation > 11000 /cumm, serum creatinine on presentation > 1.4 mg/dl, serum bilirubin on presentation >1 mg/dl and the presence of neurotoxicity were associated with poor outcome in our centre.

Key Words: anti-snake venom, neurotoxic, snake bite, vasculotoxic.

 

INTRODUCTION

Snake bite is a common medical emergency, especially in a country like India where a majority of people depend on agriculture for their livelihood. Approximately 2.8 million people are bitten by snakes in India every year. Snake bites claim as many as 46,900 lives in India every year. 1 Out of the 216 species of snakes identified in India, 52 species are poisonous. The most commonly found poisonous snakes in India are Elapidae (common cobra, king cobra and common krait), Viperidae (Russell’s viper, saw scaled viper, pit viper) and hydrophiidae (sea snakes).2 When a person is bitten by a poisonous snake, there should be no delay in taking the patient to a well-equipped hospital. The main treatment of a poisonous snake bite is timely administration of anti-snake venom (ASV) 3Several demographic, clinical and laboratory parameters can help clinicians identify patients who are at a high risk of developing complications. This can lead to better management of patients as well as proper use of resources such as anti-snake venom, mechanical ventilation, blood products and haemodialysis. 4Snakebite envenoming has been added to the priority list of neglected tropical diseases by the World Health Organization in June 2017. 5

 

OBJECTIVE

To study the profile and outcome of snake bite patients.

 

MATERIALS AND METHODS

This was a retrospective study carried out in GMERS Medical College and General Hospital, Gotri-Vadodara. It was approved by Institutional Human Ethics Committee. All patients, above the age of 18 years, admitted with history of snake bite, from 1st January 2017 to 31st December 2018, were included in this study. The records of these patients were studied for all demographic and epidemiological data, clinical and laboratory data and pre hospital care and in hospital treatment received, along with clinical course and outcome of the patients. Data was entered in Microsoft Excel and was analysed using Epi-Info software. Categorical variables have been described as frequencies and percentage. Continuous variables have been described as mean, standard deviation (SD), minimum and maximum values for range. Factors associated with death among snake bite patients have been analysed using Chi-square test. A p- value of less than 0.05 is considered to be statistically significant.

 

OBSERVATION AND RESULTS

Total 114 patients were included in this study. Table 1 shows the demographic details of these patients. Maximum patients (28.1%) were in the age group of 31 – 40 years and the least number of patients (7%) were in the age group of more than 60 years. There was a male preponderance seen as 52.6% of patients were males. A majority (82.5%) of the patients were married. Most of the patients (81.6%) resided in rural areas. More than one third of the patients (39.5 %) were farmers by occupation.


 

Table 1: Demographic profile of snake bite patients (N = 114)

Variables

Number of patients

Percentage

Age

 

 

≤ 20 years

20

17.5

21 - 30 years

28

24.6

31 - 40 years

32

28.1

41 - 50 years

17

14.9

51 - 60 years

9

7.9

More than 60 years

8

7

Gender

 

 

Male

60

52.6

Female

54

47.4

Marital status

 

 

Married

94

82.5

Unmarried

20

17.5

Residence

 

 

Rural

93

81.6

Urban

21

18.4

Occupation

 

 

Farmer

45

39.5

Non farmer

69

60.5

 

Table 2 shows the epidemiological profile of snake bite patients. More than half of the cases (64.9%) were seen in the months of July, August and September. More cases (56.1%) were reported during day time (from 7 am to 7 pm). 57 % of the incidents took place outdoors. A majority of patients (39.5 %) were working in fields when they were bitten by a snake. Almost all (99.1%) snake bites were unprovoked.

 

Table 2: Epidemiological profile of snake bite patients (N = 114)

Variables

Number of patients

Percentage

Month

 

 

January – March

1

0.9

April – June

18

15.8

July – September

74

64.9

October – December

21

18.4

Time

 

 

Day (From 7 am to 7 pm)

64

56.1

Night (From 7 pm to 7 am)

50

43.9

Place

 

 

Indoor

49

43

Outdoor

65

57

Activity

 

 

Sleeping

26

22.8

Working in field

45

39.5

Others

43

37.7

Circumstances

 

 

Provoked

1

0.9

Unprovoked

113

99.1

 

As shown in table 3, 13.2 % of the patients were referred from community health centres, 1.8% patients were referred from private hospitals and a majority of patients (85 %) came directly to our hospital. Before reaching our hospital, only 10.5 % patients received ASV, 12.3 % patients received tetanus toxoid and only 4.4% patients had applied tourniquet. 7.9% of the patients had taken some sort of traditional or folk remedy before arriving at our hospital.

Table 3: Pre hospital care received by snake bite patients (N = 114)

Pre hospital care

Number

Percentage

Referred from community health centre

15

13.2

Referred from private hospital

2

1.8

Came directly

97

85

Received ASV

12

10.5

Received tetanus toxoid

14

12.3

Tourniquet application

5

4.4

Any traditional / folk remedies taken

9

7.9

 

As shown in table 4, maximum patients (52.6%) were bitten over lower limbs. 3.5% patients were hypertensive. Most common presenting signs and symptoms were local pain (78.9%), presence of fang marks (76.3%), local swelling (74.6%), respiratory paralysis (14.9%), nausea/ vomiting (11.4%), and ptosis (10.5%). Neurological manifestations were present in 14.9% patients. Local and systemic bleeding was present in 9.6% patients.

Table 4: Clinical profile of snake bite patients (N = 114)

Variables

Number

Percentage

Site of snake bite

 

 

Upper limb

49

43.0

Lower limb

60

52.6

Axial

5

4.4

Comorbid conditions

 

 

Hypertension

4

3.5

Presence of fang marks

87

76.3

Local pain

90

78.9

Local swelling

85

74.6

Fever

7

6.1

Nausea / vomiting

13

11.4

Oliguria

1

0.9

Bleeding from bite site

7

6.1

Hematemesis

3

2.6

Haematuria

2

1.8

Ecchymosis

2

1.8

Ptosis

12

10.5

Ophthalmoplegia

3

2.6

Respiratory paralysis

17

14.9

Bulbar weakness

8

7

Weakness in limbs

2

1.8

Altered sensorium

3

2.6

Seizures

1

0.9

Local wound pain / swelling / ecchymosis within 7.5 cm of bite site

83

72.8

Local wound pain / swelling / ecchymosis extending beyond 7.5 cm of bite site but involving less than half of the limb

6

5.3

Local wound pain / swelling / ecchymosis involving more than half of the limb

1

0.9

 

As described in table 5, almost half of the patients (53.5%) reached our hospital within 4 hours of snake bite. About one third of the patients (31.6%) were critical and required intensive care. ASV was given to 87.7% of patients. 10.5% of patients required transfusion of blood products like red cell concentrate or fresh frozen plasma, 14.9% of patients required mechanical ventilation, 12.3% of patients had hypotension requiring inotropic support, 0.9% of patients had acute kidney injury requiring haemodialysis and 6.1% of patients required surgical wound debridement. Almost half of the patients (52.6%) required hospitalization for 4 or more days. A majority (91.2%) of patients were discharged.

Table 5: Hospital care in snake bite patients (N = 114)

Variables

Number

Percentage

Time interval between snake bite and hospital admission

 

 

Less than 4 hours

61

53.5

4-24 hours

45

39.5

More than 24 hours

8

7

Ward admission

78

68.4

ICU admission

36

31.6

ASV given

100

87.7

Blood products received

12

10.5

Mechanical ventilation

17

14.9

Inotropes

14

12.3

Haemodialysis

1

0.9

Wound debridement

7

6.1

Hospital stay < 4 days

54

47.4

Hospital stay ≥ 4 days

60

52.6

Patients discharged

104

91.2

Patients expired

10

8.8

 

Laboratory parameters of patients at the time of presentation to the hospital were as detailed in Table 6. Whole blood clotting time (WBCT) > 20 minutes was seen in 9.6% patients. Prothrombin time / international normalized ratio (PT/INR) was deranged (raised) in 9.6% of patients.

Table 6: Laboratory parameters of snake bite patients on presentation (N = 114)

Laboratory parameters

Mean

Standard deviation

Minimum

Maximum

Haemoglobin (g/dl)

11.35526

2.09568

6

17.7

Total leucocyte count (/cumm)

12402.11

7111.071

3100

35800

Platelets (/cumm)

242700.2

109577.1

72000

600000

Serum creatinine (mg/dl)

1.003509

0.732305

0.5

7.5

Serum bilirubin (mg/dl)

1.114035

0.795549

0.2

4.7

International Normalized Ratio

1.414035

1.133561

0.7

7

WBCT

Number

Percentage

 

 

Normal

103

90.4

 

 

Raised (>20 minutes)

11

9.6

 

 

PT/INR

Number

Percentage

 

 

Normal

103

90.4

 

 

Raised

11

9.6

 

 

 

We observed that factors significantly associated with death in snake bite patients were need for mechanical ventilation, need for inotropic support, total leucocyte count on presentation > 11000 /cumm, serum creatinine on presentation > 1.4 mg/dl, serum bilirubin on presentation >1 mg/dl and the presence of neurotoxicity. Presence of vasculotoxicity and requirement of blood product transfusion was not significantly associated with mortality.

Table 7: Factors associated with outcome of snakebite patients (N=114)

Variables

Death (n=10)

Discharge (n=104)

X2

p-value

Mechanical ventilation

8

9

31.12

<0.0001*

Blood products

3

9

2.43

0.11

Inotropes

8

6

40.02

<0.0001*

Neurotoxic snake bite

5

12

7.82

0.005*

TLC > 11000 / cumm

9

40

7.89

0.005*

S. Creatinine > 1.4 mg/dl

3

2

11.1

0.0009*

S. Bilirubin > 1 mg/dl

5

9

10.89

0.001*

Vasculotoxic snake bite

3

8

2.96

0.08

*statistically significant


DISCUSSION

In our study we analysed 114 cases of snake bite. We compared our findings with that of other studies done in India. In our study, maximum patients (28.1%) were in the age group of 31 – 40 years. Harshavardhana et al6 reported that 58% patients in his study were above the age of 40 years which differs from our study where only 29.8% patients were above the age of 40 years and 70.2% were below the age of 40 years. In our study, 52.6% of patients were males and 47.4% were female. This is similar to the male preponderance reported by Gangadharam et al7 (61.5%) and Harshavardhana et al6 (72%). In our study, a majority of the patients were married (82.5%) and resided in rural areas (81.6%). Anjum et al8 also reported that a majority of patients in their study were married (73.4%) and resided in rural areas (67.5%). In our study, a significant bulk of patients (39.5 %) was involved in farming by occupation. Anjum et al8 also reported that a majority (48.5%) of patients in their study was involved in agriculture. We observed that maximum cases were seen in the months of July, August and September (64.9%) and this is similar to the study reported by Anjum et al8 where 67.5% cases were reported in these 3 months. In our study, we noted that 57 % of the incidents took place outdoors. Anjum et al8 also reported a similar finding (62.7% outdoor snake bites). We observed that more people (56.1%) were bitten during day time (from 7 am to 7 pm) which is similar to that reported by Bhelkar et al9 (58.33% bitten during daytime). In our study, 39.5 % patients were working in fields and 22.8% patients were sleeping when they were bitten by a snake. Bhelkar et al9 reported 48.08% patients were working in fields and only 10.26% patients were sleeping when they were bitten by a snake. This differs from our study. Almost all (99.1%) snake bites in our study were unprovoked which is more than that reported by Padhiyar et al4 where 64.1% snake bites were unprovoked. In our study we noted that, 13.2 % of the patients were referred from community health centres, 1.8% patients were referred from private hospitals and maximum patients (85 %) came directly to our hospital. Padhiyar et al4 reported that in their study, 57.8% patients were referred from rural health centres, 17.2% patients were self-referred and remaining patients were referred from primary health centre and private hospitals. The number of patients who came directly to our hospital is higher. Before reaching our hospital, only 10.5 % patients received ASV, 12.3 % patients received tetanus toxoid and only 4.4% patients had applied tourniquet at or above the site of bite. This is again different from that reported by Padhiyar et al4 where 62.5% patients had received ASV, 51.6% had received tetanus toxoid and 45.3% had applied a tourniquet. This difference can be attributed to the fact that maximum patients in our study had come directly to our hospital. In our study we noted that 7.9% of the patients had taken some sort of traditional or folk remedy before arriving at our hospital which is lower than that reported by Bhelkar et a9 (30.77%). Maximum patients (52.6%) in our study were bitten over lower limbs. Anjum et al8 also reported that 69.2% patients had snake bites on lower limb in their study. Most common presenting signs and symptoms were local pain (78.9%), presence of fang marks (76.3%), local swelling (74.6%), respiratory paralysis (14.9%), nausea/ vomiting (11.4%), ptosis (10.5%), bulbar weakness (7%), bleeding from bite site (6.1%) and fever (6.1%). This is similar to findings of other studies.8, 9 We observed that neurotoxicity was present in 14.9% patients and vasculotoxicity was present in 9.6% patients. Padhiyar et al4 reported that 43.8% bites were vasculotoxic and 34.4% were neurotoxic. This was much higher than that observed in our study. Almost half of the patients (53.5%) reached our hospital within 4 hours of snake bite and only 7% patients reached after 24 hours. This is similar to that reported by Anjum et al8, where 48.5% patients reached hospital within 6 hours and only 5.9% patients reached after 24 hours. In our study 31.6% patients were critical and were admitted in intensive care unit and ASV was given to 87.7% of patients. Anjum et al8 also reported similar data (30.8% ICU admissions and 81.1% patients received ASV). In our study we observed that 10.5% of patients required transfusion of blood products like red cell concentrate or fresh frozen plasma, 14.9% of patients required mechanical ventilation, 12.3% of patients had hypotension requiring inotropic support, 0.9% of patients had acute kidney injury requiring haemodialysis. In the study reported by Padhiyar et al4, blood transfusion was required in 20.3% patients, 18.75% patients required mechanical ventilation, 6.25% received haemodialysis and 6.25% required inotropic support. In our study more patients needed inotropic support while need for blood products, mechanical ventilation and haemodialysis was less as compared to their study. In our study, a majority (91.2%) of patients were cured and discharged, while 8.8% patients expired. Anjum et al8 reported similar findings (92.3% cured and 7.7% expired). We observed that whole blood clotting time > 20 minutes was seen in 9.6% patients and raised PT/INR was seen in 9.6% of patients, which is lower than what was reported by Padhiyar et al4 (34.3% and 23.4% respectively). We observed that factors significantly associated with death in snake bite patients were need for mechanical ventilation and need for inotropic support. Padhiyar et al4 concluded that patients requiring blood product transfusion, inotropes, haemodialysis and mechanical ventilation had a statistically significant correlation with poor outcome. We did not find that requirement of blood product transfusion was significantly associated with mortality. Padhiyar et al4 also reported that acute kidney injury was significantly associated with poor outcome and hepatic involvement was not significantly associated with poor outcome. We observed that renal involvement (serum creatinine on presentation > 1.4 mg/dl) and hepatic involvement (serum bilirubin on presentation >1 mg/dl) was significantly associated with mortality. We also observed that total leucocyte count on presentation > 11000 /cumm and the presence of neurotoxicity was associated with mortality and presence of vasculotoxicity was not significantly associated with mortality.

 

CONCLUSION

Snake bite is a common medical emergency in tropics. It is more common in farmers and in monsoon. Factors like - need for mechanical ventilation, need for inotropic support, total leucocyte count on presentation > 11000 /cumm, serum creatinine on presentation > 1.4 mg/dl, serum bilirubin on presentation >1 mg/dl and the presence of neurotoxicity were associated with poor outcome in our centre.

 

REFERENCES

  1. Prevalence of snake bite envenoming – WHO. Available at https://www.who.int/snakebites/epidemiology/en/ Accessed 25 December 2019.
  2. Bawaskar HS: Snake bite poisoning. In: Munjal YP, eds. API Textbook of Medicine, 9th edition. Association of Physician of India; 2012: 1955-1959.
  3. Lei C, Badowski NJ, Auerbach PS, Norris RL. Disorders Caused by Venomous Snakebites and Marine Animal Exposures. In: Kasper, Fauci, Hauser, Longo, Jameson, Loscalzo, eds. Harrison’s Principles of Internal Medicine, 19th edition. Mac Graw -Hill Education; 2015: 2733-2744.
  4. Padhiyar R, Chavan S, Dhampalwar S, Trivedi T, Moulick N: Snake bite envenomation in a tertiary care centre: J.Assoc physicians India. 2018 Mar; 66(3):50-4.
  5. What is snakebite envenoming? - WHO. Available at https://www.who.int/snakebites/disease/en/ Accessed 25 December 2019.
  6. Harshvardhan HS, Pasha I, Srinivas prabhu NC, Ravi P, Amira N: A study on Clinico-Epidemiological profile of snake bite patients in a tertiary care centre in Bangalore: Global Journal of Medicine and Public health. 2014; 3 (2): 1-6.
  7. Gangadharam Y, Noushad Ali SK, Shabana Begum SK, Rao DS: Clinical Profile and Outcome of Envenomous Snake-Bite At Tertiary Care Centre In Nellore- A Retrospective Study: IOSR Journal of Dental and Medical Sciences. Jan 2017;16:14-19.
  8. Anjum A, Husain M, Hanif SA, Ali SM, Beg M, et al: Epidemiological Profile of Snake Bite at Tertiary Care Hospital, North India: J Forensic Res 3. 2012; 3(4): 1-5
  9. Bhelkar SM, Chilkar SD, More SM: Study of snake bite cases admitted in tertiary care hospital in Nagpur: Int J Community Med Public Health. 2017 May; 4(5):1597-1602.


















 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.